Form 4 filed by RIKER LAUREN
RIKER LAUREN filed this Form 4 on PCRX (Pacira BioSciences, Inc.) with 13 transaction rows and 0 holding rows, accepted by EDGAR 2026-11-17 21:36:01 UTC.
- Accession
- 0001628280-26-074526
- Filer
- CIK 1545439
- Filed
- 2026-11-17
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: PCRX · Pacira BioSciences, Inc. (CIK 1396814)
- RIKER LAUREN officer (Senior Vice President, Finance)
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-11-17 | U | -6,881.242 | $36.5 | 55,403 | D |
| Common Stock | 2026-11-17 | D returned to the issuer | -55,403 | $36.5 | 0 | D |
| Stock Option (Right to Buy) derivative | 2026-11-17 | D returned to the issuer | -6,250 | 0 | D | |
| Stock Option (Right to Buy) derivative | 2026-11-17 | D returned to the issuer | -15,000 | 0 | D | |
| Stock Option (Right to Buy) derivative | 2026-11-17 | D returned to the issuer | -7,500 | 0 | D | |
| Stock Option (Right to Buy) derivative | 2026-11-17 | D returned to the issuer | -6,000 | 0 | D | |
| Stock Option (Right to Buy) derivative | 2026-11-17 | D returned to the issuer | -25,000 | 0 | D | |
| Stock Option (Right to Buy) derivative | 2026-11-17 | D returned to the issuer | -11,200 | 0 | D | |
| Stock Option (Right to Buy) derivative | 2026-11-17 | D returned to the issuer | -12,000 | 0 | D | |
| Stock Option (Right to Buy) derivative | 2026-11-17 | D returned to the issuer | -6,500 | 0 | D | |
| Stock Option (Right to Buy) derivative | 2026-11-17 | D returned to the issuer | -5,000 | 0 | D | |
| Stock Option (Right to Buy) derivative | 2026-11-17 | D returned to the issuer | -14,600 | 0 | D | |
| Stock Option (Right to Buy) derivative | 2026-11-17 | D returned to the issuer | -25,000 | 0 | D |